WA
MXCT icon

Waverly Advisors’s MaxCyte MXCT Stock Holding History

Waverly Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.5K Buy
52,020
+1,753
+3% +$1.64K ﹤0.01% 1573
2025
Q4 		$77.9K Buy
50,267
+1
+0% +$2 ﹤0.01% 1439
2025
Q3 		$79.4K Buy
+50,266
New +$87.4K ﹤0.01% 1261

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Waverly Advisors's MXCT Position: Q1 2026 in Review

Waverly Advisors increased its MaxCyte (MXCT) stake by 3.5% in Q1 2026, buying an estimated $1.64K and bringing the position to 52,020 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Waverly Advisors first reported a position in MXCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $79.4K in Q3 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Waverly Advisors held 52,020 shares of MaxCyte worth $36.5K as of Q1 2026.
  • Waverly Advisors bought 1,753 MaxCyte shares in Q1 2026, an estimated $1.64K.
  • MaxCyte made up ﹤0.01% of Waverly Advisors's portfolio in Q1 2026, its #1573 holding.
  • Waverly Advisors first reported a position in MaxCyte in Q3 2025 and has held it in 3 quarters since.
  • Waverly Advisors's MaxCyte position peaked at $79.4K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.